Small Cell Lung Cancer Educational Patient Group Features Amgen Head of US Oncology Medical Affairs

(September 19, 2024) The September meeting of the LiveLung Small Cell Lung Cancer group will feature Vice President, Head of Amgen’s US Oncology Medical Affairs team, Byeong Yoon, PhD, who will discuss "An in-depth look at a recently FDA approved treatment option for ES-SCLC."

This FREE, virtual meeting will be held at 7:00 pm ET, Tuesday, September 30, 2024 and is open to all Small Cell Lung Cancer patients, survivors, and their care partners.

Byeong Yoon, PhD is Vice President, Head of Amgen’s US Oncology Medical Affairs team. In his role, Byeong oversees his team to lead the US medical affairs strategy and activities for Amgen’s oncology portfolio. He has held multiple leadership positions within Global and US Medical affairs over the past 15 years, and has been in the pharmaceutical industry for almost 20 years. During that time, he’s had the privilege of working on a number of therapies in oncology, inflammatory, and cardiovascular diseases, including helping bring new therapies to patients suffering from these diseases.
"When I was diagnosed with ES-SCLC 6 years ago, there was not even immunotherapy for people with my form of lung cancer. Now, in 2024, there are many exciting advancements in research for SCLC leading to wonderful new treatments. This gives me hope for the day I might need treatment again.” shares ES-SCLC patient and long-time LiveLung member, Maida Mangiameli. “I am very pleased that Dr. Yoon is speaking to our LiveLung family."

Small Cell Lung Cancer patients and their care partners are welcome to RSVP at
https://www.livelung.org/meetings-1/small-cell-lung-cancer.

About LiveLung
LiveLung is a 501(c)(3) nonprofit on a mission to improve health outcomes by advancing lung cancer education, early detection, and compassion for people impacted by lung cancer. We do this by hosting a network of monthly educational community lung cancer patient groups. We provide resource bags to dozens of cancer centers where nurse navigators give them to newly diagnosed lung cancer patients.